Oncocorner

Webinar

Apr
2026

00
CEST

Tumour sites CME application in progress

Escalation or de-escalation? Strategies in HER2+ breast cancer treatment

This webinar will focus on escalation and de-escalation strategies in the neo/adjuvant treatment of HER2-positive breast cancer. Experts will discuss current standards of care, key factors guiding treatment individualisation, and the implications for surgical decision-making within a multidisciplinary setting, drawing on the latest clinical evidence and real-world practice.

ACKNOWLEDGMENTS

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.

This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

Speakers

Discussant

Alexandru Eniu

Consultant Medical Oncologist at Clinique de Genolier, Genolier, Switzerland

Expert

Roisin Connolly

University College Cork and Cork University Hospital, Cork, Ireland

Expert

Adrienne G. Waks

Dana-Farber Cancer Institute, Boston, USA